Mirati Therapeutics, Inc. (NASDAQ:MRTX) Q1 2023 Earnings Conference Call May 9, 2023 4:30 PM ET

Company Participants

Ryan Asay – Vice President-Corporate Affairs

David Meek – Chief Executive Officer

Ben Hickey – Chief Commercial Officer

Alan Sandler – Chief Medical Officer

Jamie Christensen – Chief Scientific Officer

Laurie Stelzer – Chief Financial Officer

Conference Call Participants

Michael Schmidt – Guggenheim

Tyler Van Buren – TD Cowen

Gena Wang – Barclays

Jonathan Miller – Evercore ISI

Mike Ulz – Morgan Stanley

Ben Burnett – Stifel

Maury Raycroft – Jefferies

Silvan Tuerkcan – JMP Securities

Eric Joseph – JPMorgan

Yigal Nochomovitz – Citi

Andy Fleszar – B. Riley Securities

Jay Olson – Oppenheimer

Ami Fadia – Needham

Operator

Good afternoon, and welcome to the Mirati Therapeutics First Quarter 2023 Earnings Call. My name is Justin, and I will be the operator for today’s call. [Operator Instructions]

It is my pleasure to introduce Ryan Asay, Vice President of Corporate Affairs at Mirati. Ryan, you may begin the call.

Ryan Asay

Thank you, Justin, and welcome everyone to this afternoon’s call. Joining me on the call today are David Meek, our Chief Executive Officer; Dr. Chuck Baum, our President, Founder and Head of Research and Development; Dr. Alan Sandler, our Chief Medical Officer; Dr. Jamie Christensen, our Chief Scientific Officer; Ben Hickey, our Chief Commercial Officer; and Laurie Stelzer, our Chief Financial Officer.

Before we begin, I would like to inform you that certain statements we make during this call will be forward looking. Because such statements deal with future events and are subject to many risks and uncertainties, actual results may differ materially from those in the forward-looking statements. For a full discussion of these risks and uncertainties, please review our annual report on Form 10-K and our quarterly reports on Form 10-Q that are filed with the U.S. Securities and Exchange Commission.

This afternoon, we released financial results for the quarter ended March 31, 2023 and recent corporate updates. This press release is available on the Investors section of our website at mirati.com.

With that, David, I’ll turn the call over to you.

David Meek

Thank you, Ryan, and thank you all for joining us on the call today. On this afternoon’s call, I will provide initial remarks before turning the call over to Ben, Alan, Jamie and Laurie to provide updates I’ll then provide some closing remarks before we open the line for questions.